Increased prevalence of metabolic syndrome in patients with psoriatic arthritis

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 1, 2014, Pages 43-48

  Pehlevan, Seval ^a   Yetkin, Demet Ozgil ^b   Bahadir, Cengiz ^c   Goktay, Fatih ^d   Pehlevan, Yekta ^e   Kayatas, Kadir ^d   Ince, Nurhan ^f  

^a Sema Hastanesi Istanbul   (Turkey)

^b Bayindir Hastanesi ^*  (Turkey)

^c Erenkoy Physical Medicine and Rehabilitation Hospital   (Turkey)

^d Haydarpasa Numune Training Hospital   (Turkey)

^e Pendik State Hospital   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; ROUTINE ASSESSMENT OF PATIENT INDEX DATA; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, PSORIATIC; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84892546931     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0039     Document Type: Article

References (27)

1. Sidiropoulos PI, Karvounaris SA, Boumpas DT. Metabolic syndrome in rheumatic diseases: Epidemiology, pathophysiology, and clinical implications. Review. Arthritis Res Ther 2008;10:207
2. Pereira RMR, de Carvalho JF, Bonfá E. Metabolic syndrome in rheumatological diseases. Autoimmun Rev 2009;8:415-19
3. Han C, Robinson DW Jr, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. J Rheumatol 2006;33:2167-2172 (Pubitemid 44749774)
4. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007;57: 1074-1080 (Pubitemid 47237336)
5. Eder L, Zisman D, Barzilai M, et al. Subclinical atherosclerosis in psoriatic arthritis: A case-control study. J Rheumatol2008;35:877-882 (Pubitemid 351747131)
6. Reilly MP, Rader DJ. The metabolic syndrome: More than the sum of its parts? Circulation 2003;108:1546-1551
7. Krook A. IL-6 and metabolism - new evidence and new questions. Diabetologia 2008;51:1097-1099
8. Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez- Ramírez G, et al. Obesity and inflammation: Epidemiology, risk factors, and markers of inflammation. Int J Endocrinol2013;2013:678159
9. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007;36:203-209 (Pubitemid 46188476)
10. Tam L-S, Tomlinson B, Chu T T-W, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls - The role of inflammation. Rheumatology 2008;47:718-723 (Pubitemid 351619219)
11. Tobin AM, Veale DJ, Fitzgerald O, et al. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis (review). J Rheumatol 2010;37:1386-1391
12. Jones SM, Harris CP, Lloyd J, et al. Lipoproteins and their subfractions in psoriatic arthritis: Identification of an atherogenic profile with active jointdisease.AnnRheumDis 2000;59:904-909
13. Taylor W, Gladman D, Helliwell P, et al., and the CASPAR Study Group. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-2673 (Pubitemid 44205029)
14. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-2291
15. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joints count: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48
16. Pincus T, Yazici Y, Bergman M. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol 2007;21:755-787 (Pubitemid 47163602)
17. Feldman SR, Fleischer Jr AB, Reboussin DM, et al. The Self- Administered Psoriasis Area and Severity Index is valid and reliable. J Invest Dermatol 1996;106:183-186 (Pubitemid 26052065)
18. National Cholesterol Education Program. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
19. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva: World Health Organisation, 1999
20. Reilly MP, Wolfe ML, Rhodes T, et al. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110:803-809 (Pubitemid 39096007)
21. Raychaudhuri SK, Chatterjee S, Nquyen C, et al. Increased prevalence of the metabolic in patients with psoriatic arthritis. Metab Syndr Relat Disord 2010;8:331-334
22. Mok CC, Ko GTC, Ho LY, et al. Prevalence of atherosclerotic risk factors and themetabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res 2011;63:195-202
23. Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996;19:112-118 (Pubitemid 26039130)
24. Axelsen M, Eliasson B, Joheim E, et al. Lipid intolerance in smokers. J Intern Med 1995;237:449-455
25. Westlake SL, Colebatch AN, Baird J, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review. Rheumatology (Oxford) 2010;49:295-307
26. Sattar N, Crompton P, Cherry L, et al. Effect of tumour necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-bind, placebo-controlled study. Arthritis Rheum 2007;56:831-839 (Pubitemid 46399431)
27. Davis JM, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: What is the true direction of the effect? J Rheumatol 2005;32:1856-1862 (Pubitemid 41429009)